Zoetis Inc Stock Filter Stocks by Fundamentals
ZTS Stock | USD 168.51 2.84 1.71% |
Zoetis Inc fundamentals help investors to digest information that contributes to Zoetis' financial success or failures. It also enables traders to predict the movement of Zoetis Stock. The fundamental analysis module provides a way to measure Zoetis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zoetis stock.
Zoetis | Shares Owned by Institutions |
Zoetis Shares Owned by Institutions Analysis
2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 96M | 259M | 31M | 29.5M | Depreciation | 448M | 465M | 491M | 320.7M |
Zoetis Shares Owned by Institutions Driver Correlations
Understanding the fundamental principles of building solid financial models for Zoetis is extremely important. It helps to project a fair market value of Zoetis Stock properly, considering its historical fundamentals such as Shares Owned by Institutions. Since Zoetis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zoetis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zoetis' interrelated accounts and indicators.
Click cells to compare fundamentals
Competition |
Based on the latest financial disclosure, Zoetis Inc has a Shares Owned by Institutions of 0.0null. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Shares Owned by Institutions (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Zoetis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zoetis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zoetis' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Zoetis Institutional Holders
Institutional Holdings refers to the ownership stake in Zoetis that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zoetis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zoetis' value.Shares | Wellington Management Company Llp | 2023-12-31 | 9 M | Goldman Sachs Group Inc | 2023-12-31 | 9 M | Fmr Inc | 2023-12-31 | 7.9 M | Nuveen Asset Management, Llc | 2023-12-31 | 6.5 M | Northern Trust Corp | 2023-12-31 | 5.9 M | Polen Capital | 2023-12-31 | 5 M | Norges Bank | 2023-12-31 | 5 M | Bank Of New York Mellon Corp | 2023-12-31 | 4.4 M | Legal & General Group Plc | 2023-12-31 | 4.2 M | Vanguard Group Inc | 2023-12-31 | 40.3 M | Blackrock Inc | 2023-12-31 | 36.5 M |
Zoetis Fundamentals
Return On Equity | 0.5 | ||||
Return On Asset | 0.13 | ||||
Profit Margin | 0.27 % | ||||
Operating Margin | 0.32 % | ||||
Current Valuation | 81.87 B | ||||
Shares Outstanding | 457.87 M | ||||
Shares Owned By Insiders | 0.24 % | ||||
Shares Owned By Institutions | 95.40 % | ||||
Number Of Shares Shorted | 3.77 M | ||||
Price To Earning | 43.89 X | ||||
Price To Book | 15.44 X | ||||
Price To Sales | 9.03 X | ||||
Revenue | 8.54 B | ||||
Gross Profit | 5.63 B | ||||
EBITDA | 3.56 B | ||||
Net Income | 2.34 B | ||||
Cash And Equivalents | 3.58 B | ||||
Cash Per Share | 5.88 X | ||||
Total Debt | 6.8 B | ||||
Debt To Equity | 1.48 % | ||||
Current Ratio | 2.18 X | ||||
Book Value Per Share | 10.90 X | ||||
Cash Flow From Operations | 2.35 B | ||||
Short Ratio | 1.64 X | ||||
Earnings Per Share | 5.07 X | ||||
Price To Earnings To Growth | 2.90 X | ||||
Target Price | 225.85 | ||||
Number Of Employees | 14.1 K | ||||
Beta | 0.87 | ||||
Market Capitalization | 77.16 B | ||||
Total Asset | 14.29 B | ||||
Retained Earnings | 10.29 B | ||||
Working Capital | 4.45 B | ||||
Current Asset | 3.83 B | ||||
Current Liabilities | 1.78 B | ||||
Z Score | 9.61 | ||||
Annual Yield | 0.01 % | ||||
Five Year Return | 0.55 % | ||||
Net Asset | 14.29 B | ||||
Last Dividend Paid | 1.5 |
About Zoetis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zoetis Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zoetis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zoetis Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis Inc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 12100 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out Zoetis Piotroski F Score and Zoetis Altman Z Score analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Zoetis Stock analysis
When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Zoetis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zoetis. If investors know Zoetis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zoetis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.164 | Dividend Share 1.5 | Earnings Share 5.07 | Revenue Per Share 18.527 | Quarterly Revenue Growth 0.085 |
The market value of Zoetis Inc is measured differently than its book value, which is the value of Zoetis that is recorded on the company's balance sheet. Investors also form their own opinion of Zoetis' value that differs from its market value or its book value, called intrinsic value, which is Zoetis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zoetis' market value can be influenced by many factors that don't directly affect Zoetis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zoetis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zoetis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zoetis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.